Search
Filters
-
Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials
…ital led, Alphabet/GV/Temasek/MGX/CapitalG). No AI-designed drug has ever entered a human trial; first trials …
…ital led, Alphabet/GV/Temasek/MGX/CapitalG). No AI-designed drug has ever entered a human trial; first trials …